Editorial Board
Editors in Chief, Section Editors & Editorial Board
Antonio Giordano
Professor at the Department of Biology, Temple University in Philadelphia, where he is also Director and founder of the Sbarro Institute for Cancer Research and Molecular Medicine. He is also Professor of Anatomic Pathology at Siena University, Italy. Worked at Cold Spring Harbor Laboratories directed by Nobel Laureate James Watson. Giordano research activity mainly focused on the study of the mechanisms underlying cell cycle deregulation in cancer and other human diseases. He discovered key regulators of the cell cycle such as RBL2/p130, CDK9 and CDK10 and its pioneering studies contributed to the understanding of crucial mechanisms of cancer development.
As a researcher, he has authored more than 600 articles, received over 30 awards for his contributions to cancer genetics and human diseases .
Giordano is a member of the editorial board of several international journals.
Carmine Pinto
Degree in Medicine and Surgery at the University of Naples, and board of Oncology and then of Hematology at the University of Bologna, he is Director of Medical Oncology Unit of the AUSL-IRCCS of Reggio Emilia. Member of several national and international scientific societies, from November 2014 to October 2017 he was National President of the Italian Association of Medical Oncology (AIOM), and currently President of the Federation of Italian Cooperative Oncology Groups (FICOG). Author of over 250 scientific publications in national and international journals and member of different scientific societies such as the American Society of Clinical Oncology (ASCO). Reviewer of international research projects for Cancer Research Campaign (CRC), Clinical Trials Committee of the United Kingdom and the French Institute National du Cancer (INCa). He has been responsible for the conduction of over 90 clinical and translational studies.
Francesca Pentimalli
Associate Professor of General Pathology, PhD in Cellular and Molecular Genetics and Specialist in Clinical Pathology and Clinical Biochemistry at the Department of Medicine and Surgery of LUM University Giuseppe Degennaro (Bari, Italy).
Adjunct Associate Professor at the Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA.
She obtained her Degree in Biological Sciences summa cum laude in 1997, her PhD in Molecular and Cellular Genetics in 2002, and Specialized in Clinical Pathology and Biochemistry at the University of Naples Federico II, Italy. From 2001 to 2006 she worked as Post-Doctoral Fellow first at the Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, then at the University Federico II, School of Medicine. From 2006 to 2007 she worked as Assistant Editor for Nature Reviews Cancer and Nature Reviews Genetics in London, UK. From 2008, she has been working at the National Cancer Institute of Naples leading the Cell Cycle and Cancer Lab. She authored over a hundred articles in the field of cancer genetics and therapeutics.
Daniele Santini
Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy
Diego Serraino
S.O.C. Epidemiologia e Biostatistica, Aviano, Italy
Mattia Barbareschi
Director of the Unit of Surgical Pathology, Director of the Department of Laboratory Medicine, S. Chiara Hospital, Trento, Italy
Nunzio Del Gaudio
Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy
Rosaria Benedetti
Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy
Romano Danesi
UO Farmacologia clinica e Farmacogenetica, Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy
Domenico Corsi
Director, UOC Oncologia Ospedale San Giovanni Calibita Fatebenefratelli, Rome, Italy
Elvio Russi
Department of Radiotherapy and Radiology, A.O. S. Croce e Carle, Cuneo, Italy
Arnolfo Petruzziello
UOC Clinical Pathology, Department of Diagnostic Services, AORN S. Anna e S. Sebastiano, Caserta, Italy
Riccardo Caccialanza
Director, UOC Dietetics and Clinical Nutrition, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Paolo Pedrazzoli
UOC Oncologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Department of Internal Medicine and Medical Therapy, Università di Pavia
Massimo Di Maio
Department of Oncology, Università degli Studi di Torino, SCDU Medical Oncology, AO Ordine Mauriziano, Torino, Italy
Luciano Mutti
RCPI Medical Oncology, Chairman of the Italian Group for Research and Therapy for Mesothelioma (GIMe)
Marco Benasso
S.C. Oncologia Ospedale San Paolo, Savona, Italy/Ospedale Santa Corono, Pietra Ligure, Italy
Orazio Caffo
Medical Oncology Department, Santa Chiara Hospital, Trento, Italy
Alba Brandes
Department of Medical Oncologyt, Azienda USL of Bologna, Bologna, Italy
Mario Mandalà
Professor of Medical Oncology, University of Perugia, Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy
Giuseppe Palmieri
Institute of Genetic & Biomedical Research (IRGB) at National Research Council (CNR), University of Sassari, Sassari, Italy
Nicola Fazio
Director of the Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors. and Director of the Program in Digestive and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy
Roberto Lucchini
Department of Occupational and Environmental Health, Robert Stempel College of Public Health and Social Work, Miami/Florida International University, Miami, USA/Occupational Medicine University of Brescia, Brescia, Italy
Marcella Barbarino
Biomedical Technologies and Experimental Oncology Lab, Department of Biomedical Technologies, University of Siena, Siena, Italy
Lucia Altucci
Department of Precision Medicine, Luigi Vanvitelli University of Campania, Caserta, Italy
Antonio Maria Grimaldi
Melanoma, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale dei Tumori IRCCS Fondazione G. Pascale, Naples, Italy
PRASHANT KHARKAR
Department of Pharmaceutical Science, Institute of Chemical Technology (ICT), Mumbai, India
Prashant Kumar
Dean – Research Somaiya Vidyavihar University (SVU) & Director, Somaiya Institute for Research And Consultancy (SIRAC), Mumbai, India. Faculty Scientist, Institute of Bioinformatics, Bangalore, India
Claudio Cerchione
MD, PhD, Hematology Unit, Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” – IRST IRCCS, Meldorla, Forl-Cesena, Italy
Anna Crispo
Statistical Researcher, Complex Structure of Epidemiology and Biostatistics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy
Umberto Malapelle
Chair of Predictive Molecular Pathology Laboratory, Associate Professor at Department of Public Health, Federico II University of Naples, Naples, Italy
Massimo Barberis
Andrea Morrione
Director, Molecular Mechanisms of Cancer Signal Transduction Program Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology College of Science and Technology Temple University, PA, US
Giovanni Grignani
Sarcoma Unit, Istituto di Candiolo – IRCCS, Candiolo, Turin, Italy
Amalia Luce
Department of Precision Medicine, Luigi Vanvitelli University of Campania, Naples, Italy
Marco Vanoni
Department of Biotechnology and Bioscience , Università di Milano Bicocca, Milan, Italy
Simona Sperlongano
Claudio Mauro
Institute of Inflammation and Ageing, Institute of Cardiovascular Sciences, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Sendurai Mani
Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, Texas, USA
Francesco Graziano
Department of Onco-Hematology, Division of Oncology, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Italy
Giuseppe Toffoli
Clinical and Experimental Pharmacology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN) , Italy
Paolo Giorgi Rossi
Epidemiology Unit, Azienda USL di Reggio Emilia – IRCCS, Reggio Emilia, Italy
Tiziano Tuccinardi
Department of Pharmacy, University of Pisa, Pisa, Italy
Gennaro Daniele
Clinical Trials Unit, Istituto Nazionale Tumori, Fondazione G Pascale, IRCCS, Naples, Italy
Italo Tempera
Department of Microbiology and Immunology, The Fels Institute, Temple School of Medicine, Philadelphia, PA, US
Augusto Caraceni
Palliative Care, Pain Therapy and Rehabilitation, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
Filippo Montemurro
Multidisciplinary Oncology Outpatient Clinic, Istituto di Candiolo, FPO-IRCCS , Candiolo, Italy
Maria Grazia Ghi
Oncology Unit, IRCCS – Istituto Oncologico Veneto, Padua, Italy
Pierluigi Scalia
Biology Department, Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA, US. Istituto Somatogene per la Ricerca Onco-Genomica, ISOPROG, Caltanissetta, Italy
Giuseppe Procopio
Director, Medical and Genitourinary Oncology, Fondazione Istituto Nazionale Tumori, Milan , Italy
Fernando De Vita
Department of Precision Medicine, Medical Oncology, Luigi Vanvitelli University of Campania, Naples, Italy
Alessandro Comandone
SC Oncology, ASL Turin, Italy
Bruno Vincenzi
Department of Medical Oncology, University Campus Bio-Medico, Rome, Italy
Giovanni Baglio
Italian National Agency for Regional Healthcare Services (AGENAS), Rome, Italy
Renato Franco
Department of Mental and Physical Health and Preventive Medicine, Pathology Unit, Luigi Vanvitelli University of Campania, Naples, Italy
Paola Indovina
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA. Institute for High Performance Computing and Networking, National Research Council of Italy (ICAR-CNR), Naples, Italy
Luigi Alfano
Oncology Research Center of Mercogliano (CROM), Istituto Nazionale Per Lo Studio e La Cura Dei Tumori – Fondazione Giovanni Pascale, IRCCS, Naples, Italy
Davide Ruggero
Department of Urology, School of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA
Antonio Feliciello
Professor of General Pathology, Department of Molecular Medicine andMedical Biotechnologies, University of Naples Federico II, Naples, Italy
Enrico Franceschi
Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, IRCCS Institute of Neurological Sciences, Bologna, Italy
Haining Yang
Thoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii
Khamel Khalili
Department of Neuroscience, Department of Microbiology, Immunology & Inflammation, Center for Neurovirology & Gene Editing, Comprehensive NeuroAIDS Center, Temple University , PA, US
Gary Stein
Director, University of Vermont Cancer Center – Professor and Chairperson, Department of Biochemistry – Professor, Department of Surgery, Burlington, Vermont, US
Gualberto Gussoni
Scientific Director at Centro Studi FADOI, Milan, Italy
Department of Clinical Research
Stephen J. Williams
Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA
Marco Merlano
Director, S.C. Oncology, Ospedale San Paolo, Savona, Ospedale Santa Corono, Pietra Ligure, Italy
